Wednesday 21 Nov, 2018 04:13 PM
Site map | Locate Us | Login
   DCM Shriram Ltd leads losers in 'A' group    Minda Corporation jumps after reducing stake in JV company    Hotel Leela Venture Ltd leads losers in 'B' group    Volumes soar at Prestige Estates Projects Ltd counter    Adani Gas hits the roof    Zee Media Corporation Ltd down for fifth straight session    Oil & Natural Gas Corpn Ltd drops for fifth straight session    Power Finance Corporation Ltd soars 2.04%, Gains for third straight session    Reliance Infrastructure Ltd up for third consecutive session    Adani Gas Ltd leads gainers in 'B' group    SpiceJet Ltd leads gainers in 'A' group    Aviation stocks take off    Rajesh Exports bucks trend after bagging export order     Volumes spurt at Minda Corporation Ltd counter    Sonata Software Ltd Slides 3.1%, S&P BSE IT Sector index Shed 1.99% 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Suven Life Sciences gains after securing product patents in Israel, Japan
06-Nov-18   11:14 Hrs IST

The announcement was made during trading hours today, 6 November 2018.

Meanwhile, the S&P BSE Sensex was up 113.38 points, or 0.32% to 35,064.30.

On the BSE, 18,000 shares were traded in the counter so far compared with average daily volumes of 86,000 shares in the past two weeks. The stock had hit a high of Rs 245.50 and a low of Rs 239.55 so far during the day. The stock hit a 52-week high of Rs 337.70 on 11 September 2018. The stock hit a 52-week low of Rs 163.30 on 23 March 2018.

Suven Life Sciences (Suven) announced securing the grant of one product patent from Israel and one product patent from Japan corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases. Patents are valid through 2036 and 2034 respectively.

The granted claims of the patents include the class of selective M1 PAM and 5-HT4 compounds respectively and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia etc.

Net profit of Suven Life Sciences rose 31.35% to Rs 38.84 crore on 34.51% rise in net sales to Rs 184.88 crore in Q1 June 2018 over Q1 June 2017.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.G Anand , anand@ssplwealth.com
Hit Count : 9833698
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd